XML 34 R23.htm IDEA: XBRL DOCUMENT v3.4.0.3
Compensatory Equity Incentive Plan and Other Equity Incentives (Tables)
9 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share based compensation award plans

These plans are summarized below:

      Award Shares  Available for
   Award Shares  Outstanding  Issuance
   Authorized  at March 31,  at March 31,
Equity Compensation Arrangement     2016  2016
 Amended and Restated Omnibus Incentive Plan   3,915,625    2,126,055    1,144,429 
 Employee Stock Purchase Plan   400,000    —      390,094 
                
    4,315,625    2,126,055    1,534,523 
Schedule of stock options fair value assumptions

For stock options granted in the nine month periods ended March 31, 2016 and 2015, we estimated the fair value of each stock option as of the date of grant using the following assumptions:

   Nine months ended  Nine month ended
   March 31, 2016  March 31, 2015
Expected volatility  68% - 103%  118%
Weighted average expected volatility  68% - 103%  118%
Dividend yields  0%  0%
Risk-free interest rate  0.37% - 1.49%  1.76%
Expected term, in years  4.29 - 7.50  7.50
Schedule of share based compensation awards activity

A summary of the activity for share-based compensation awards in the nine months ended March 31, 2016 is presented below:

            Restricted
      Stock Options     Stock Units (RSUs)
      Weighted  Weighted     Weighted
      Average  Average     Average
      Exercise  Remaining     Remaining
      Price  Contract     Contract
   Shares  (per share)  Life (YRS)  Shares  Life (YRS)
June 30, 2015   722,483   $2.08    5.3    1,075,300    0.9 
                          
Granted   150,592   $1.48    9.6    236,495    2.6 
Exercised   (6,077)  $1.07    3.3    —      —   
Cancelled/Forfeited   (52,738)  $3.26    —      —      —   
                          
March 31, 2016   814,260   $1.90    5.8    1,311,795    1.0 
                          

Awards exercisable/vested as of

March 31, 2016

   637,010   $2.06    5.1    870,196    —   
                          

Awards unexercisable/unvested as of

March 31, 2016

   177,250   $1.34    8.3    441,599    1.0 
    814,260              1,311,795     
Schedule of share based compensation future cost to be recognized

We expect to recognize the compensation cost as follows: 

 

      Restricted   
      Stock   
   Stock  Share/   
   Options  Units  Total
Three months ended June 30, 2016  $12,083   $74,953   $87,036 
                
Year ended June 30, 2017   41,429    237,187    278,616 
                
Year ended June 30, 2018   27,661    141,580    169,241 
                
Year ended June 30, 2019   11,923    29,153    41,076 
                
Year ended June 30, 2020   1,684    —      1,684 
   $94,780   $482,873   $577,653 
Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards

The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of March 31, 2016 and changes during the nine months then ended:

Unexercisable/unvested awards  Stock
Options
Shares
  RSU Shares  Total
Shares
  Weighted-Average
Grant Date Fair Values
(per share)
June 30, 2015   224,500    403,870    628,370   $1.10 
Granted   150,592    236,495    387,087   $1.39 
Vested   (197,842)   (198,766)   (396,608)  $1.20 
Cancelled/Forfeited   —      —      —      —   
March 31, 2016   177,250    441,599    618,849   $1.35 

 

Schedule of financial statement effect related to share based compensation

The following table shows total stock-based compensation expense for the nine months ended March 31, 2016 and 2015 included in the consolidated statements of comprehensive income (loss):

 

   (Unaudited)  (Unaudited)
   Nine months ended  Nine months ended
   March 31,  March 31,
   2016  2015
 Stock options  $37,125   $40,343 
 RSU   224,489    171,172 
      Total  $261,614   $211,515 
           
 The amounts above were included in:          
 Selling, general & administrative  $260,449   $203,214 
 Cost of sales   238    79 
 New product development   927    8,222 
   $261,614   $211,515